Preventive healthcare is a vital component of modern health systems, aiming to maintain good health and prevent the onset of disease through organised measures. In the European Union (EU), tracking expenditure on preventive healthcare services offers insights into public health priorities and the extent to which countries invest in long-term population wellbeing. Data from Eurostat illustrates that preventive care consistently accounts for a small proportion of total health expenditure, though variations between countries are considerable. The classification of these services, combined with detailed spending analysis by country and provider type, offers a structured understanding of how prevention is financed across the region. 

Scope and Classification of Preventive Care 

Preventive healthcare expenditure encompasses services with the primary goal of averting disease or injury, including early detection and health promotion activities. It is categorised within the System of Health Accounts (SHA) as one of several healthcare functions and is typically carried out by health professionals, often within public health institutions or non-profit organisations. In Eurostat’s statistical framework, preventive care includes measures such as immunisation, disease control programmes and health education, while excluding activities related to curative treatment, rehabilitation or long-term care. 

In terms of classification, preventive care is reported as a distinct function (HC.6) and subdivided into four detailed components: maternal and child health; school health services; prevention of communicable diseases; and prevention of non-communicable diseases. The focus remains on population-wide interventions rather than individual-level treatments. Data collection follows the joint health data questionnaire developed by Eurostat, OECD and WHO, ensuring consistency in national reporting. 

Must Read: EU Health Spending: Trends and Priorities 

Levels and Shares of Expenditure Across the EU 

In 2021, current healthcare expenditure on preventive care in the EU stood at €106 billion, representing approximately 2.8% of total current healthcare expenditure. This proportion has remained relatively stable over the last decade, fluctuating between 2.7% and 2.9%. Despite its critical role, preventive care remains one of the smaller components of health spending, both in absolute terms and as a percentage of GDP or per capita expenditure. 

Substantial variation exists among EU Member States in both the amount and share of preventive care expenditure. For example, in 2021, Italy recorded the highest share, with preventive care accounting for 6.3% of its total health expenditure. Other countries such as Finland, the Netherlands and Malta also reported relatively high shares exceeding 5%. In contrast, several countries allocated less than 2% of their total health spending to prevention, including Slovakia, Romania and Cyprus. 

When measured per capita, the highest expenditure on preventive care was observed in Luxembourg, which spent €645 per inhabitant, followed by the Netherlands, Finland and Denmark. Conversely, some eastern and southern European countries reported much lower per capita spending. The differences reflect not only policy priorities but also broader structural and economic factors influencing national health systems. 

Providers and Financing Schemes of Preventive Services 

Preventive healthcare services are predominantly delivered by government institutions, public health agencies and non-profit organisations. In many countries, these entities account for the majority of prevention expenditure, particularly in the case of population-wide initiatives like vaccination campaigns or health screenings. Hospitals and ambulatory care providers also play a role, though their share in preventive care is generally smaller compared to their role in curative services. 

Data from 2021 reveal that in 14 EU countries, more than 80% of preventive care expenditure was managed by providers of public health programmes. This was especially true in Ireland, Latvia and Portugal. In contrast, countries like Germany and France reported a more diversified provider mix, including ambulatory healthcare providers and hospitals contributing a higher share to prevention services. 

The financing of preventive care also varies considerably across Member States. Government schemes and compulsory health insurance remain the dominant funding sources in most countries, reflecting the central role of public funding in supporting population health initiatives. However, the share of voluntary schemes, including private insurance and household out-of-pocket payments, differs widely. In some countries, preventive services are almost exclusively publicly funded, whereas in others, households contribute a notable share to services such as vaccinations or health checks. 

Preventive healthcare expenditure in the EU, while stable in relative terms, continues to represent a modest portion of total health spending. Considerable differences between countries highlight divergent policy choices, economic capacities and healthcare delivery structures. Public institutions remain the primary providers and funders of preventive care, underlining its status as a public health responsibility. 

Source: Eurostat 

Image Credit: iStock